ketoconazole has been researched along with remogliflozin etabonate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowers, GD; Castellino, S; Culp, AG; Dobbins, RL; Humphreys, JE; Hussey, EK; Kapur, A; O'Connor Semmes, RL; Polli, JW; Reese, MJ; Sigafoos, JF; Tao, W; Wagner, DS | 1 |
1 trial(s) available for ketoconazole and remogliflozin etabonate
Article | Year |
---|---|
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies.
Topics: Administration, Oral; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Glucosides; Glucuronides; Half-Life; Humans; Ketoconazole; Male; Microsomes, Liver; Middle Aged; Pyrazoles; Risk; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2012 |